Skip to main content
. 2018 Feb 6;9:173. doi: 10.3389/fimmu.2018.00173

Figure 2.

Figure 2

MicroRNA (miR)-146a, miR-155 in tumor necrosis factor (TNF) receptor-associated periodic fever syndrome (TRAPS) and healthy control (HC) dermal fibroblast (DF) following graded lipopolysaccharide (LPS) challenge. TRAPS (n = 3) and HC (n = 4) DF miR-146a and miR-155 RNA expression (A,B) measured by Taqman qPCR. Data were converted to a logarithmic scale base 10. The two-way ANOVA (p = ≤ 0.05) test was used to determine statistical significance.